Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)
      Google Scholar   
Citation:
Journal of Clinical Oncology vol 42 (3_suppl) 664
Meeting Instance:
ASCO GI 2024
Year:
2024
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4342  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180868 (NRG); U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                 
Networks:
LAPS-NY016, LAPS-TX035, NORTHWELL, OH070   
Study
Alliance-A021501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: